Explores neurogenic cough treatment effectiveness via superior laryngeal nerve block, indicating potential benefits.
SLN block may be offered as a treatment for neurogenic cough after guideline-directed evaluation and treatment for other causes have been attempted. There is an ~80% success rate which may require multiple injections. Risks appear limited; however, long-term benefit is not yet determined.
No takes yet. Share an insight, caveat, or question.
Tracy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: